COVID-19 Test Market: $33BN in Revenues in 2021, Future Still a Guess

Kalorama has just completed a report on the COVID-19 in vitro diagnostic testing market.  2021 was a year in which point-of-care antigen tests, lab-based PCR tests, rapid PCR and even home tests were available to the market.  Also antibody tests, NGS tests and other tests were brought to bear in diagnosing cases. The scourge of […]

Point-of-Care (POC) Diagnostic Testing: 5 Key Trends to Watch from 2022-2026

Globally, millions of dollars are spent annually on point-of-care (POC) diagnostic testing, both professional testing (which includes physician office labs, clinic labs, employer labs and hospital labs) and self-testing (which includes home, drug store testing and continuous glucose testing).  In 2021, amidst the pandemic, the POC market reached $41,149 million ($41.1 billion) and the market […]

At-Home Diagnostic Testing: COVID-19 Has Consumers More Comfortable with Tests for Infectious Diseases

The global at-home in vitro diagnostics (IVD) testing market had sales of $20.5 billion in 2021, up more than 35% from the previous year, largely due to increased testing in the infectious disease segment. Glucose testing and COVID-19 testing accounted for the majority of sales, according to leading medical market researcher Kalorama Information in the […]

12 Recent Developments in Cell and Gene Therapy as of April 22, 2022

There have been a number of recent developments in cell and gene therapy, as detailed in our bimonthly newsletter, Cell and Gene Therapy Business Outlook. In public offering news, Massachusetts-based Selecta Biosciences has announced a $38.7 million public offering to continue developing ImmTOR, its antigen-specific immune tolerance platform. Leading the private financing news, Cambridge-based cell […]

106 Billion IVD Procedures and Counting

“Medical market researcher Kalorama Information forecasts exponential growth in both in vitro diagnostics (IVD) procedures and sales between 2021 and 2026.”   The global in vitro diagnostics (IVD) procedures market continues to grow off momentum originating at the height of the pandemic and lingering on today. There are currently 106,624 million (106 billion) in vitro […]

Infectious Disease Testing Expected to Grow Beyond COVID-19

While COVID-19 has made the need for  in vitro diagnostics (IVD) that can detect infectious diseases front and center, demand for these tests was building before the pandemic and revenues for test products will grow says a report from a major publisher of IVD market research.    The industry consists of tests and related products […]

COVID-19 and 6 Other Trends Impacting the In Vitro Diagnostics (IVD) Market

  “In many ways, the IVD testing market is center stage for the fight against the coronavirus…The COVID-19 market continues to play a major role in the growth of the IVD market with tests for the virus representing 27% of sales in 2021.” – Kalorama Information   Make no mistake, the in vitro diagnostics (IVD) […]

13 Recent Developments in Cell and Gene Therapy as of April 8, 2022

There have been a number of recent developments in cell and gene therapy, as detailed in our bimonthly newsletter, Cell and Gene Therapy Business Outlook. Bristol Myers Squibb, based in New York, NY, has announced that the European Commission (EC) has granted Marketing Authorization for Breyanzi (lisocabtagene maraleucel; liso-cel), its CD19-targeted chimeric antigen receptor (CAR)-T […]

Pets are Key to $3.5 Billion Veterinary Diagnostic Testing Market

  “Companion animals (including dogs, cats, and horses) account for 70% of overall market, finds new report by Kalorama Information” – Kalorama Information   In the global veterinary diagnostic testing market, the companion animal segment (pets and domestic animals including horses) comprises almost 70% of the $3,540 million ($3.5 billion) overall market, with the food […]

Molecular Point of Care Market Reaches 3.5 Billion

The molecular point of care market reached 3,555 million in 2021, according to Kalorama Information’s latest report. The Market and Potential for Molecular Point-of-Care. COVID-19 sales were the main driver. That is 10x growth in revenues from 2019.  The COVID-19 pandemic and consistent arrival of variants are the determining factor, and the continued presence of […]